Related Experiment Video

Updated: Jul 16, 2026

DNA Vector-based RNA Interference to Study Gene Function in Cancer
13:10

DNA Vector-based RNA Interference to Study Gene Function in Cancer

Published on: June 4, 2012

Nonviral delivery vehicles for use in short hairpin RNA-based cancer therapies

John S Vorhies1, John Nemunaitis

  • 1Mary Crowley Medical Research Center, 1717 Main St, Suite 6000, Dallas, TX 75201, USA. jsvorhies@gmail.com

Expert Review of Anticancer Therapy
|March 7, 2007
PubMed

Insights

Short hairpin RNA (shRNA) therapeutics offer precise gene disruption for cancer treatment. Nonviral delivery vehicles show promise for effective shRNA delivery into cancer cells, overcoming current limitations.

Area of Science:

  • Biotechnology
  • Molecular Biology
  • Cancer Therapeutics

Background:

  • Short hairpin RNA (shRNA) mediated RNA interference is a precise method for gene expression disruption.
  • Effective in vivo delivery of shRNA therapeutics into target cancer cell nuclei remains a significant challenge for cancer treatment.
  • Nonviral gene delivery vehicles are being explored for their potential in human shRNA therapeutics due to their safety and efficiency.

Purpose of the Study:

  • To review promising nonviral gene delivery vehicles for shRNA therapeutics.
  • To focus on the potential application of these vehicles in cancer therapy.

Main Methods:

  • Literature review of current nonviral gene delivery vehicles.
  • Analysis of preclinical data regarding safety, immunoresistance, and transfection efficiency.

Main Results:

  • Nonviral delivery vehicles demonstrate an acceptable safety profile.
  • These vehicles exhibit resistance to immune defenses.
  • Good transfection efficiency has been observed with nonviral delivery systems.

Conclusions:

  • Nonviral gene delivery vehicles are a promising strategy for overcoming shRNA therapeutic delivery challenges in cancer.
  • Further research into these vehicles could advance the development of effective cancer shRNA therapies.

More Related Videos

Evaluation of the Efficacy And Toxicity of RNAs Targeting HIV-1 Production for Use in Gene or Drug Therapy12:03

Evaluation of the Efficacy And Toxicity of RNAs Targeting HIV-1 Production for Use in Gene or Drug Therapy

Published on: September 5, 2016

Lentiviral Mediated Delivery of shRNAs to hESCs and NPCs Using Low-cost Cationic Polymer Polyethylenimine (PEI)06:49

Lentiviral Mediated Delivery of shRNAs to hESCs and NPCs Using Low-cost Cationic Polymer Polyethylenimine (PEI)

Published on: May 24, 2022

Related Concept Videos

Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
siRNA - Small Interfering RNAs02:30

siRNA - Small Interfering RNAs

Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
RNA Interference01:23

RNA Interference

RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
Subviral Agents01:29

Subviral Agents

Subviral agents are infectious entities that resemble viruses but lack one or more viral components, such as a capsid or essential replication machinery. These agents include viroids, prions, and satellites, each possessing distinct structural and functional characteristics that influence their mode of infection and replication.Viroids are the simplest subviral agents, consisting of circular, single-stranded RNA molecules without a protein coat. They exclusively infect plants, relying entirely...